GIMAP5 and lung adenocarcinoma: In summary, CT imaging and RNA sequencing analysis of benign and malignant nodules, combined with a nomogram, suggest that CST1 and GIMAP1-GIMAP5 are potential biomarkers for lung adenocarcinoma of GGNs, providing new insights into its pathogenesis and treatment.